C12N 2770/14023
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2770/14023 (Virus like particles [vlp]) appears on 17 US grants and 41 published applications in this corpus.
Search patents in C12N- Granted patents
- 17
- Published applications
- 41
- Assignees
- 19
- Inventors
- 51
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 2 |
| 2006 | 1 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 2 |
| 2018 | 0 | 1 |
| 2019 | 1 | 2 |
| 2020 | 2 | 4 |
| 2021 | 4 | 3 |
| 2022 | 2 | 4 |
| 2023 | 1 | 2 |
| 2024 | 0 | 4 |
| 2025 | 2 | 6 |
| 2026 | 1 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Modified virus-like particles of CMV21 Apr 2026US 12,605,454 B2Saiba GmbH
- Treatment of insect bite hypersensitivity18 Feb 2025US 12,226,475 B2UniversitäT ZüRich
- Plant viral RNA delivery nanoparticles and uses thereof21 Jan 2025US 12,203,073 B2Case Western Reserve University
- Covalently fused viral coat proteins for the display of target molecules4 Apr 2023US 11,618,771 B2Fraunhofer USA, Inc.
- Treatment of insect bite hypersensitivity12 Jul 2022US 11,382,970 B2UniversitäT ZüRich
- Modified virus-like particles of cmv10 Sep 2026US 2026/0263612 A1Saiba GmbH
- Veterinary compositions of modified virus-like particles of cmv and ngf antigens12 Mar 2026US 2026/0069668 A1
- Modified virus-like particles of cmv26 Feb 2026US 2026/0055428 A1Saiba Animal Health AG
- Treatment of insect bite hypersensitivity4 Dec 2025US 2025/0367273 A1UniversitäT ZüRich
- Active vaccination for the treatment of ngf-related disorders11 Sep 2025US 2025/0281584 A1Boehringer Ingelheim Vetmedica GmbH
Most cited
By later US patents
- Virion-constrained nanoparticles comprising a plant virion coat protein shell and encapsulated guest molecules25US 6,180,389 B2The Research and Development Institute, Inc. · 2001
- Nanoscale particles synthesized within an assembled virion20US 6,984,386 B2The Research and Development Institute, Inc. · 2006
- Modified virus-like particles of CMV4US 10,532,107 B2Saiba GmbH · 2020
- Treatment of insect bite hypersensitivity2US 10,556,003 B2UniversitäT ZüRich · 2020
- Treatment of peanut allergy1US 10,898,569 B2Allergy Therapeutics (UK) Limited · 2021